Clinical Trial: Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781644) titled 'Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease' on Aug. 20.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of RO7568282 compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Parkinson's Disease

Intervention: DRUG: RO7568282

RO7568282 will be administered as per the schedule specified in the protocol.

DRUG: Placebo

Placebo will be administered as per the schedule specified in the protocol.

Recruitment S...